{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:47:39Z","timestamp":1792788459863,"version":"4.5.0"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008299","name":"Dartmouth College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009342","name":"Aeras Global Tuberculosis Vaccine Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009342","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jack and Dorothy Byrne Foundation"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0175215","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T14:26:57Z","timestamp":1494599217000},"page":"e0175215","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":73,"title":["Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901"],"prefix":"10.1371","volume":"12","author":[{"given":"C. Fordham","family":"von Reyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Lahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Arbeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leway","family":"Kailani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa V.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda C.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Wieland-Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth I.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Tvaroha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hokey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-publhealth-031912-114431","article-title":"Prospects for tuberculosis elimination","volume":"34","author":"C Dye","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1073\/pnas.1404386111","article-title":"Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries","volume":"111","author":"GM Knight","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.vaccine.2016.02.079","article-title":"Status of vaccine research and development of vaccines for tuberculosis","volume":"34","author":"TG Evans","year":"2016","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"LJ Abu-Raddad","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(14)70033-5","article-title":"Progress in tuberculosis vaccine development and host-directed therapies\u2014a state of the art review","volume":"2","author":"SH Kaufmann","year":"2014","journal-title":"Lancet Respir Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"PEM Fine","year":"1995","journal-title":"Lancet"},{"key":"ref7","first-page":"1334","article-title":"Identification of tuberculous infected:dual tests and density of reaction","volume":"108","author":"L Edwards","year":"1973","journal-title":"Am Rev Respir Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/cir951","article-title":"Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis","volume":"54","author":"JR Andrews","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref9","first-page":"155","article-title":"Protective inoculation against human tuberculosis with heat-killed tubercle bacilli","volume":"29","author":"EL Opie","year":"1939","journal-title":"Am J Hyg"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1164\/arrd.1959.80.5.676","article-title":"Vaccination against tuberculosis with non-living vaccines. I. The problem and its historical background","volume":"80","author":"DW Weiss","year":"1959","journal-title":"Am Rev Respir Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/bmj.1.5336.973","article-title":"BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life","volume":"1","year":"1963","journal-title":"Brit Med J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e22074","DOI":"10.1371\/journal.pone.0022074","article-title":"Polyantigenic interferon-gamma responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization","volume":"6","author":"T Lahey","year":"2011","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine","volume":"24","author":"CF von Reyn","year":"2010","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1016\/j.vaccine.2010.09.041","article-title":"Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania","volume":"28","author":"T Lahey","year":"2010","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1097\/00002030-200311070-00010","article-title":"Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial","volume":"17","author":"J Vuola","year":"2003","journal-title":"AIDS"},{"issue":"Suppl 3","key":"ref16","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1086\/313880","article-title":"Safety and immunogenicity of a 5 dose series of inactivated <italic>Mycobacterium vaccae<\/italic> vaccination for the prevention of HIV-associated tuberculosis","volume":"30","author":"RD Waddell","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref17","unstructured":"FDA (2007) FDA Guidance for Industry. Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/cid\/ciu331","article-title":"BCG, latitude and environmental mycobacteria","volume":"59","author":"CF von Reyn","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"LC Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed <italic>Mycobacterium leprae<\/italic> vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1005667","DOI":"10.1371\/journal.ppat.1005667","article-title":"CD4 T Cell-Derived IFN-gamma Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease","volume":"12","author":"S Sakai","year":"2016","journal-title":"PLoS Pathog"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0175215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T18:19:18Z","timestamp":1540232358000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0175215"}},"subtitle":[],"editor":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0175215","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]}}}